東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Antibody therapy = substitution - im...

Imbach, Paul.

Linked to FindBook

Google Book

Amazon

博客來

Antibody therapy = substitution - immunomodulation - monoclonal immunotherapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Antibody therapy/ edited by Paul Imbach.
Reminder of title:	substitution - immunomodulation - monoclonal immunotherapy /
other author:	Imbach, Paul.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	xiv, 363 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Immunoglobulins - Therapeutic use. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-68038-5
ISBN:	9783319680385

Antibody therapy = substitution - immunomodulation - monoclonal immunotherapy /
Antibody therapysubstitution - immunomodulation - monoclonal immunotherapy /[electronic resource] :edited by Paul Imbach. - Cham :Springer International Publishing :2018. - xiv, 363 p. :ill., digital ;24 cm.

This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice) The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP) Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.

ISBN: 9783319680385

Standard No.: 10.1007/978-3-319-68038-5doiSubjects--Topical Terms:

684853
Immunoglobulins
--Therapeutic use.

LC Class. No.: QR186.7 / .A585 2018

Dewey Class. No.: 616.0792

Antibody therapy = substitution - immunomodulation - monoclonal immunotherapy /
LDR:02003nmm a2200301 a 4500 001 2137116
003 DE-He213
005 20181015141251.0
006 m d
007 cr nn 008maaau
008 181117s2018 gw s 0 eng d
020 $a 9783319680385 $q (electronic bk.)
020 $a 9783319680378 $q (paper)
024 7 $a 10.1007/978-3-319-68038-5 $2 doi
035 $a 978-3-319-68038-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QR186.7 $b .A585 2018
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
082 0 4 $a 616.0792 $2 23
090 $a QR186.7 $b .A629 2018
245 0 0 $a Antibody therapy $h [electronic resource] : $b substitution - immunomodulation - monoclonal immunotherapy / $c edited by Paul Imbach.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xiv, 363 p. : $b ill., digital ; $c 24 cm.
520 $a This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice) The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP) Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
650 0 $a Immunoglobulins $x Therapeutic use. $3 684853
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Hematology. $3 808260
650 2 4 $a Immunology. $3 611031
650 2 4 $a Oncology. $3 751006
700 1 $a Imbach, Paul. $3 2072891
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-68038-5
950 $a Medicine (Springer-11650)